31/08/2023: Appendix 4D and Half-year Financial Report

31/07/2023: Quarterly review for the period ended 30 June 2023

02/06/2023: Notification regarding unquoted securities - JTL (2)

02/06/2023: Notification regarding unquoted securities - JTL

31/05/2023: Results of Annual General Meeting

31/05/2023: AGM Presentation

31/05/2023: Chairman's Address to Shareholders

28/04/2023: Quarterly review for the period ended 31st March 2023

28/04/2023: Proposed issue of securities - JTL

28/04/2023: Proposed issue of securities - JTL

28/04/2023: Notice of annual general meeting/proxy Form

13/04/2023: Change of director's interest notice

13/04/2023: Appendix 3Y - late lodgement notice

30/03/2023: Variation from preliminary final report

17/03/2023: Notification regarding unquoted securities

17/03/2023: Notification of cessation of securities

02/03/2023: Results of general meeting

02/03/2023: Section 708A cleansing notice

02/03/2023: Application for quotation of + securities

21/02/2023: Proposed issue of securities

03/02/2023: Notice of general meeting

31/01/2023: Jayex executes binding term sheet for health analytics joint venture with Shine Clinical Ltd

31/01/2023 Proposed issue of securities

31/01/2023: Q4 review for period ended 31 December 2022

30/01/2023: Trading halt

30/01/2023: Pause in trading

09/01/2023: Chief Financial Officer resignation

05/12/2022: Change of director's interest notice

30/11/2022: Operational update

25/11/2022: Proposed restructure of convertible notes

16/11/2022: Director resignation

16/11/2022: Final director's interest notice

26/09/2022: Jayex appoints Chief Executive Officer

30/06/2022: Financial report for the half-year ended - 30 June 2022

29/08/2022: Variations to convertible note deed & loan agreements

26/05/2022: Chairman's address to shareholders

26/05/2022: Results of annual general meeting

27/04/2022: Correction 31 March 2022 appendix 4C

27/04/2022: March 2022 quarterly update and appendix 4C

07/04/2022: Notification of cessation of +securities

31/03/2022: Variation from preliminary final report

26/10/2021: Board Structure Update

22/09/2021: Change in substantial holding

22/09/2021: Change of Director's Interest Notices x3

22/09/2021: Application for quotation of securities - JTL

21/09/2021: Response to ASX Price Query

21/09/2021: Pause in Trading

20/09/2021: Entitlement Offer Results

14/09/2021: ASIC Media Release

01/09/2021: Appendix 4D Half-Year Report

05/08/2021: Rights Issue Cleansing Notice under section 708AA(2)(f)

05/08/2021: Proposed issue of securities - JTL

05/08/2021: Equity Raising to Raise up to $1.83 million

30/07/2021: June 2021 Quarterly Activities Report & Appendix 4C

30/07/2021: Reinstatement to Official Quotation

30/07/2021: Jayex Technology agrees strategic investment into Brainworks Foundry, Inc.

28/07/2021: Suspension from Official Quotation

26/07/2021: Trading Halt

30/06/2021: Change of Director's Interest Notice

08/06/2021: Broker briefing investor webinar

8/05/2021: Change of Company Name and ASX Code

27/05/2021: Results of Annual General Meeting

27/05/2021: AGM Presentation

27/05/2021: Chairman's Address to Shareholders

26/05//2021: AGM Attendance Protocols

24/05/2021: Proposed issue of Securities - JHL

24/05/2021: JHL Placement raising $0.57m

20/05/2021: Trading Halt

17/05/2021: Jayex Healthcare Limited Completes Divestment

10/05/2021: Variation to Jayex Healthcare Binding Term Sheet

07/05.2021: Partial repayment of Convertible Notes

04/05/2021: Quarterly review for the period ended 31 March 2021 and trading update

13/04/2021: Jayex divests Acute (hospital) queue management business

12/04/2021: JHL sub obtains Cultivation Licence for Medical Marijuana

08/04/2021: Notice of Annual General Meeting/Proxy Form

30/03/2021: Jayex subsidiary completes cannabis licensing inspection

12/03/2021: Appendix 4G and Corporate Governance Statement

12/03/2021: Annual Report

26/02/2021: Appendix 4E Preliminary Final Report

29/01/2021: Quarterly review for the period ending 31 December 2020 and Trading Update

16/12/2020: Jayex Operating Update

09/12/2020: Response to ASX Price Query

09/11/2020: Amendment to 30 September 2020 Appendix 4C

29/10/2020: September 2020 Quarterly Update and Appendix 4C

14/10/2020: Change of Director's Interest Notice

13/10/2020: Cleansing Statement and Appendix 3G - Convertible Notes

01/10/2020: Change of Director's Interest Notice

01/10/2020: Results of General Meeting

07/09/2020: Section 708A Notice and Appendix 2A

02/09/2020: Proposed Issue of Securities

02/09/2020: Non-Executive Director Appointment

02/09/2020: Jayex Completes $700K Capital Raise

02/09/2020: Appendix 3X Initial Director's Interest Notice

31/08/2020: Trading Halt

28/08/2020: Appendix 4D and Half-year Financial Report

27/08/2020: Notice of General Meeting/Proxy Form

31/07/2020: 2019 Annual General Meeting

31/07/2020: Results of Annual General Meeting

31/07/2020: Proposed Convertible Note Issue and Debt Conversion

27/07/2020: Change of Auditor

24/07/2020: Quarterly & half-year review for the period ended 30 June 2020 and business update

01/07/2020: Change of Director's Interest Notice

30/06/2020: Change of Director's Interest Notice

29/06/2020: Resignation of CEO and Managing Director

11/06/2020: Jayex signs Licence Agreement with Lifespot Health

04/06/2020: AGM Date and Director Nomination Closing Date

19/05/2020: JHL receives funding in form of COVID-19 support

28/04/2020: March 2020 Quarterly Update and Appendix 4C

16/04/2020: COVID-19 (Coronavirus Pandemic) Market Update - Correction

09/04/2020: COVID—19 (Coronavirus Pandemic) Market Update

25/03/2020: Defferal of Annual General Meeting

24/03/2020: Appendix 4G Corporate Governance Council Principles and Recommendations

24/03/2020: Annual Report

04/03/2020: Section 708A Notice and Appendix 2A

28/02/2020: Notice under Section 708A(5)(e)of the Corporations Act 2001

28/02/2020: Appendix 4E Preliminary Final Report

10/02/2020: Response to ASX Appendix 4C query

22/01/2020: Jayex Technology Ltd enters joint venture with LYPHE Group

09/12/2019: Jayex enters Partnership with Microtech Group

06/12/2019: Final Director's Interest Notice

06/12/2019: Registration of Director

15/11/2019: Appendix 3Y Change of Director's Interest Notice

31/10/2019: Quarterly Cash Flow Report and Trading Update

13/09/2019: Change of share registry details

30/08/2019: Appendix 4D and Half-year Financial Report

26/07/2019: Appendix 4C Quarterly

22/07/2019: Mutual Termination on Consulting Contracts

12/06/2019: Change in Substantial Holding 

03/06/2019: Section 708A Notice and Appendix 3B

31/05/2019: Response to ASX Price Query

30/05/2019: Trading Halt

30/05/2019: Pause in Trading

24/05/2019: Results of Annual General Meeting

24/05/2019: CEO Presentation

08/05/2019: NZ Medical Cannabis -Research Facility Approval 

30/04/2019: Appendix 3B

30/04/2019: Appendix 4C - Quarterly

24/04/2019: Annual Report to Shareholders 

23/04/2019: Notice of Annual General Meeting/Proxy Form

08/04/2019: Change of Director's Interest Notice M. Boyd

08/04/2019: Change of Director's Interest Notice - Correction

02/04/2019: Change of Director's Interest Notice M. Boyd

28/03/2019: Annual Report

28/03/2019: Apppendix 4G & 2018 Corporate Governance Statement

27/03/2019: Appendix 3Y Change of Director's Interest Notice

28/02/2019: Appendix 4E

18/02/2019: Revised NZ Medical Cannabis and Technology Commercialisation Strategy

31/01/2019: Quarterly Cash Flow Report

29/10/2018: Appendix 4C - Quarterly Cash Flow Report

23/10/2018: Termination of License Agreement

25/07/2018: Appendix 4C - Quarterly 

25/07/2018: Change of Director's Interest Notice

20/07/2018: Retraction of Announcement

14/07/2018: Section 708A Notice and Appendix 3B

10/07/2018: JHL executes Binding Licence Agreement with Medicann

19/06/2018: Appendix 3B New Issue Announcement

08/06/2018: Notice of Change of Interests of Substantial holder

08/06/2018: Notice of Change of Interests of Substantial holder

07/06/2018: Appendix 3Y Change of Director's Interest Notice

05/06/2018: Change of Principal Place of Business

05/06/2018: Appendix 3Y Change of Director's Interest Notice

05/06/2018: Appendix 3B New Issue Announcement

05/06/2018: Appendix 3Y Change of Director's Interest Notice

25/05/2018: 2018 AGM  Presentation

25/05/2018: Results of Annual General Meeting 2018

23/04/2018: Notice of Annual General Meeting, Explanatory Statement and Proxy Form

27/02/2018: Appendix 4G & 2017 Corporate Governance Statement

27/02/2018: Appendix 4E and 2017 Annual Report

31/01/2018: Appendix 4C – quarterly

25/01/2018: Loan Agreement

08/01/2018: Discontinuance of Legal Proceedings

15/12/2017: Appendix 3B

14/12/2017: Loan Agreement

04/12/2017: Loan Agreement

01/12/2017: Release of Securities from Escrow

24/11/2017: Section 708A Notice and Appendix 3B

17/11/2017: Loan Agreement

16/11/2017: Response to ASX Appendix 4C Query

31/10/2017: Appendix 4C – Quarterly

11/10/2017 : Loan Agreement (JHL)

02/10/2017 : Change of Director’s Interest Notice

26/09/2017 : Change of Director’s Interest Notice

22/09/2017 : Change of Director’s Interest Notice

22/08/2017 : Appendix 4D and Interim Financial Report

31/07/2017 : Appendix 4C – quarterly

03/07/2017 : Change of Director’s Interest Notice

03/07/2017 : Change of Director’s Interest Notice

24/05/2017 : Results of Annual General Meeting

24/05/2017 : 2017 AGM Presentation

24/05/2017 : Chief Executive Officer Appointment

23/05/2017 : Loan Facility Finalised

15/05/2017 : Change of Director’s Interest Notice

28/04/2017 : JHL-Appendix 4C

21/04/2017 : 2016 Annual Report to shareholders

21/04/2017 : Notice of Annual General Meeting/Proxy Form

28/02/2017 : Apppendix 4G & 2016 Corporate Governance Statement

28/02/2017 : Appendix 4E and 2016 Annual Report

31/01/2017 : Appendix 4C – Quarterly

12/01/2017 : Section 708A Notice and Appendix 3B

09/12/2016 : Change of Director’s Interest Notice

29/11/2016 : Jayex Healthcare wins four-year contract with Cohealth

31/10/2016 : Appendix 4C – quarterly

28/10/2016 : Change of Principal Place of Business

18/10/2016 : Section 708A Notice and Appendix 3B

12/10/2016 : Market Update

04/10/2016 : Market Update

30/09/2016 : Appendix 3B – Release of Escrow

29/09/2016 : Change of Director’s Interest Notice

22/09/2016 : Change of Director’s Interest Notice

22/09/2016 : Appendix 3B – Release of Escrow

14/09/2016 : Change of Director’s Interest Notice

15/09/2016 : Market update

06/09/2016 : Release of Securities from Escrow

31/08/2016 : First Half 2016 Results Review

31/08/2016 : Appendix 4D and Interim Financial Report

08/08/2016 : Corporate Update

01/08/2016 : Resignation of Director

29/07/2016 : Appendix 4C – quarterly

13/07/2016 : Resignation of Director

20/06/2016 : Announcement Title: Section 708A Notice and Appendix 3B

24/05/2016 : Results of Annual General Meeting

24/05/2016 : 2015 AGM Presentation

17/05/2016 : Change of Director’s Interest Notice

11/05/2016 : Investor Presentation – May 2016

09/05/2016 : Change of Director’s Interest Notice

02/05/2016 : Appointuit – PKF Settlement

29/04/2016 : Appendix 4C – Quarterly Report

29/04/2016 : 2015 Annual Report to shareholders

22/04/2016 : JHL 2016 AGM NOM & Proxy form for Website

04/04/2016 : Change of Director’s Interest Notice

30/03/2016 : Securities Trading Policy – Updated

30/03/2016 : Apppendix 4G & 2015 Corporate Governance Statement

30/03/2016 : Full Year Statutory Accounts

24/03/2016 : Jayex UK – Port of Dover Contract Update

29/02/2016 : Appointuit Litigation

29/02/2016 : Preliminary Final Report – Appendix 4E

03/02/2016 : New Issue Announcement – Appendix 3B

29/01/2016 : Quarterly Cash Flow Report

15/01/2016 : Expansion into Allied Healthcare Key-Management Appointments

14/01/2016 : Appendix 3X – Initial Directors Interest Notice

18/12/2015 : Becoming a Substantial Holder – A Jain

17/12/2015 : Becoming a substantial holder – M Boyd

17/12/2015 : Becoming a substantial holder – Jayex Healthcare Limited

17/12/2015 : Initial Director’s Interest Notice – S Tanner

17/12/2015 : Initial Director’s Interest Notice – J Allinson

17/12/2015 : Initial Director’s Interest Notice – B Renwick

17/12/2015 : Initial Director’s Interest Notice – M Boyd

17/12/2015 : Jayex Healthcare lists on the ASX